Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-17

Clinical Trial Update: Improvement of Fish Oil in Obesity With Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to evaluate the effect of fish oil on obesity with mild cognitive impairment. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil

Snippet

Sponsor: Weiwei Ma | Conditions: Obesity, Mild Cognitive Impairment | Phase 4 | Status: NOT_YET_RECRUITING